{
    "ticker": "IMUX",
    "name": "Imunon, Inc.",
    "description": "Imunon, Inc. is a clinical-stage biotechnology company focused on developing innovative immunotherapy treatments for cancer and infectious diseases. Founded in 1994, the company is dedicated to advancing its proprietary platform technologies to improve patient outcomes. Imunon is known for its work in harnessing the body\u2019s immune system to target and destroy cancer cells. Its lead product candidate, IMU-838, is a novel oral small molecule that is being evaluated for the treatment of multiple indications, including autoimmune diseases and viral infections. The company is also developing a range of other immunotherapy candidates aimed at enhancing the immune response to tumors. Imunon seeks to transform the landscape of cancer treatment through its unique approach and has made significant strides in its clinical trials, positioning itself as a promising player in the biotechnology sector. With a commitment to scientific excellence and innovation, Imunon aims to bring effective therapies to market that can significantly improve the quality of life for patients battling serious health challenges.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Gaithersburg, Maryland, USA",
    "founded": "1994",
    "website": "https://www.imunon.com",
    "ceo": "William D. McCarthy",
    "social_media": {
        "twitter": "https://twitter.com/ImunonInc",
        "linkedin": "https://www.linkedin.com/company/imunon-inc/"
    },
    "investor_relations": "https://www.imunon.com/investor-relations",
    "key_executives": [
        {
            "name": "William D. McCarthy",
            "position": "CEO"
        },
        {
            "name": "Gregory W. P. R. K. H. K. W. S. F. H. J. R. B.",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Immunotherapy",
            "products": [
                "IMU-838",
                "IMU-100"
            ]
        }
    ],
    "seo": {
        "meta_title": "Imunon, Inc. | Innovative Immunotherapy Solutions",
        "meta_description": "Explore Imunon, Inc., a leading clinical-stage biotechnology company focused on developing immunotherapy treatments for cancer and infectious diseases.",
        "keywords": [
            "Imunon",
            "Biotechnology",
            "Immunotherapy",
            "Cancer Treatment",
            "Clinical Trials",
            "IMU-838"
        ]
    },
    "faq": [
        {
            "question": "What is Imunon, Inc. known for?",
            "answer": "Imunon, Inc. is known for its development of innovative immunotherapy treatments for cancer and infectious diseases."
        },
        {
            "question": "Who is the CEO of Imunon?",
            "answer": "William D. McCarthy is the CEO of Imunon, Inc."
        },
        {
            "question": "Where is Imunon headquartered?",
            "answer": "Imunon is headquartered in Gaithersburg, Maryland, USA."
        },
        {
            "question": "What are Imunon's main products?",
            "answer": "Imunon's main products include IMU-838 and IMU-100, which are in various stages of clinical development."
        },
        {
            "question": "When was Imunon founded?",
            "answer": "Imunon was founded in 1994."
        }
    ],
    "competitors": [
        "NVS",
        "BMY",
        "MRNA",
        "REGN"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "VRTX",
        "RHHBY"
    ]
}